JAPANESE

Japan College of Rheumatology

Hamamatsu-cho Empress Bldg. 3F, 2-9-6
Hamamatsu-cho, Minato-ku, Tokyo 105-0013, JAPAN
TEL: +81-3-6435-9761
FAX: +81-3-6435-9762
URL:
https://eng.ryumachi-jp.com/
E-mail:
gakkaih@ryumachi-jp.com
facebook iconx icon

Congress Secretariat

c/o Congrès Inc.
Onward Park Bldg., 3-10-5 Nihonbashi, Chuo-ku Tokyo 103-8276, JAPAN
TEL: +81-3-3510-3701
FAX: +81-3-3510-3702
E-mail:support@jcr2024.com
x icon

English Session

[As of Feb. 15, 2024]

Thursday, April 18

S4: Recent advances in systemic autoimmune diseases

LS1:Modern management strategies for RA: achieving clinical and structural remission with filgotinib

LS3:Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine

LS11:Update on the management of ILD in rheumatic diseases

LS12:Rheum Up to DateーPatient Based Risk Assessment in RA―

LS14:Clinical significance of IL-23 in the treatment of Psoriatic arthritis

S7: New insight into the pathogenesis of glucocorticoid-induced osteoporosis

ES2:Latest evidence update of a JAK inhibitor drug

Friday, April 19

MS7:Rheumatoid Arthritis Treatment Updates: Focus on The Evolution of IL-6 Inhibition Therapy in EULAR Recommendations

MTE 11: What would you do, physical exam? – Musculoskeletal system: UCSF way

SS2: APLAR activities: recent understandings of important clinical issues and recent translational research investigations(APLAR Session)

MTE12: What would you do, physical exam? – Rheumatology: Scandinavian way

RS: From Housewife to Prime Minister. Reflections on Finland’s Way toward a Gender Equal Society

LS16:Modernizing the clinical approach to RA management by preventing structural joint damage: the JAK inhibitor filgotinib

SS3: Updates and Perspectives in Rheumatology(EULAR Session)

EL17: Osteoarthritis -Current Knowledge for Rheumatologists-

EL18: Up-dated Perioperative Management of Anti-rheumatic Medication in Patients undergoing Othopaedic Surgeries

ES9:Critical role of IL-6 Inhibition for Autoimmune Diseases

ES18:Treatment of Spondyloarthritis aiming for higher outcomes

Saturday, April 20

MS13:(draft) Treatment Strategy for RA

MS14:Up-to-date evidence in RA and SpA treatment

S15: New insights into pathogenesis of rheumatoid arthritis

TS: TREG Session

S19: Young Rheumatologists International Interactive Session (J-STAR Session)

SS4: System biology and mechanism-based therapy in rheumatic disease(ACR Session)

Representative Session

From Housewife to Prime Minister. Reflections on Finland’s Way toward a Gender Equal Society

Friday, April 19 11:00-11:50 Room 1 ( Portopia Hall, 1F, South Building, Kobe Portopia Hotel )

Chair: Michiaki Takagi Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
Speaker: Nina Santavirta Faculty of Educational Sciences, University of Helsinki, Finland

Symposium

S 4

Thursday, April 18 9:30-12:00 Room 11 (International Conference Room, 3F, Kobe International Conference Center)

Recent advances in systemic autoimmune diseases

Chairs:  Yuko Kaneko Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Japan
Peter C. Taylor Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK

S4-1Management options in "difficult to treat" rheumatoid arthritis

Peter C. Taylor Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK

S4-2Advances in systemic lupus erythematosus

Yoshiya Tanaka The First Department of internal Medicine, University of Occupational and Environmental Health, Japan

S4-3Management of interstitial lung disease associated with systemic autoimmune diseases

Masataka Kuwana Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Japan

S4-4Update on treatment of ANCA-associated vasculitis

Bernhard Hellmich Medius Kliniken, University of Tübingen, Kirchheim-Teck, Germany

S4-5Still's disease: EULAR / PReS guidelines for the diagnosis and management of Still's disease

Bruno Fautrel Sorbonne University / Assistance Publique - Hopitaux de Paris, France

S 7

Thursday, April 18 14:05-16:35 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )

New insight into the pathogenesis of glucocorticoid-induced osteoporosis

Chairs: Takeshi Miyamoto Department of Orthopedic Surgery, Kumamoto University, Japan
Kunihiro Yamaoka Kitasato University School of Medicine, Japan

S7-1Overview of glucocorticoid-induced osteoporosis

Yoshiya Tanaka The First Department of internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

S7-2Fracture-risks in patients with glucocorticoid-induced osteoporosis

Mary B. Humphrey Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, UK

S7-3Mechanisms and assessment of glucocorticoid-induced osteoporosis

Kenneth G. Saag University of Alabama at Birmingham, USA

S7-4Surgical treatment and management of glucocorticoid-induced osteoporosis

Kosuke Ebina Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine / Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Japan

S7-5Pharmacological treatment of glucocorticoid-induced osteoporosis

Kunihiro Yamaoka Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan

S 15

Saturday, April 20 8:40-11:10 Room 11 (International Conference Room, 3F, Kobe International Conference Center)

New insights into pathogenesis of rheumatoid arthritis

Chairs: Hiroshi Takayanagi Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan
George Kollias Department of Physiology, Medical School, University of Athens, Athens, Greece

S15-1Synovial Macrophage in Joint Homeostasis and Inflammation

Gerhard Krönke Charité, Universitätsmedizin Berlin, Germany

S15-2Immunogenetics to understand the etiology of autoimmunity

Kazuyoshi Ishigaki Laboratory for Human Immunogenetics, RIKEN Center for Integrative Medical Sciences, Japan

S15-3Fibroblasts as regulators of inflammation and damage in arthritis

Adam P. Croft Rheumatology Research Group, University of Birmingham, Birmingham, UK

S15-4The immune-stromal-bone interaction in autoimmune arthritis

Noriko Komatsu Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Japan

S15-5FIBROBLAST-DRIVEN PATHOGENIC MECHANISMS IN JOINT/GUT AXIS DISEASES

George Kollias Department of Physiology, Medical School, University of Athens, Athens, Greece

S 19

Saturday, April 20 14:40-16:40 Room 7 ( Kairaku 3, B1, Main Building, Kobe Portopia Hotel )

Young Rheumatologists International Interactive Session

Chairs: Masaru Kato Rheumatology and Nephrology, Hokkaido University Hospital, Japan
Masayuki Nishide Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan

S19-1A case of adult-onset Still’s disease with tendonitis and tenosynovitis -including ultrasound assessment-

Sho Sendo Department of Clinical Laboratory/ Division of Rheumatology and Clinical Immunology, Kobe university hospital, Japan

S19-2Developing a EULAR network of early career researchers dedicated to lung diseases in inflammatory rheumatisms.

Pierre Antoine Juge Service de Rhumatologie, Hopital Bichat Claude Bernard, Paris, France

S19-3Modifications of T cell phenotype with TYK2 Inhibitor and its implications for the treatment of Systemic lupus erythematosus (SLE)

Yurie Satoh Kanda The 1st Department of Internal Medicine, University of Occupatinal and Environmental Health, Japan

S19-4From clinical observation to data analysis: a case report on IgG4-related kidney disease and evaluating infection risks of rituximab in anti-neutrophil cytoplasmic antibody-associated vasculitis through network meta-analysis

Meng-Ko Tsai Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei / Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung / Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan

S19-5Omics analysis of severe complications of autoimmune diseases

Wataru Fujii Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan

S19-6EMEUNET- aspirational goals for a harmonised community

Latika Gupta University of Manchester / Royal Wolverhampton NHS Trust, UK

Special Symposium

SS 2(APLAR Session)

Friday, April 19 8:40-10:40 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )

APLAR activities: recent understandings of important clinical issues and recent translational research investigations

Chairs: Tsutomu Takeuchi Saitama Medical University / Keio University School of Medicine, Japan
Atsushi Kawakami Department of Immunology and Rheumatology Division of Advanced Preventive Medical Sciences Nagasaki University Graduate School of Biomedical Sciences, Japan

SS2-1Musculoskeletal ultrasound for Rheumatic musculoskeletal diseases in resource limited set up

Farzana Shumy Square Hospitals LTD Dhaka, Bangladesh

SS2-2Pregnancy and Rheumatic diseases in APLAR region

Samar Al Emadi Division of Rheumatology, Department of Medicine, HMC, Oman

SS2-3Systemic autoinflammatory disease in adults: diagnostic approach and treatment

Hugh C. Caterson Prince of Wales Hospital, Sydney, Australia

SS2-4Synovial tissue heterogeneity and predominant inflammatory signal in Japanese patients with rheumatoid arthritis.

Sotaro Nakajima Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

SS2-5Single cell analysis reveals the diversity of rheumatic diseases

Masayuki Nishide Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan

SS 3(EULAR session)

Friday, April 19 15:10-17:10 Room 11( International Conference Room, 3F, Kobe International Conference Center )

EULAR Updates and Perspectives in Rheumatology

Chairs: Kunihiro Yamaoka Kitasato University School of Medicine, Japan
Yukinori Okada Department of Genome Informatics, Graduate School of Medicine, the University of Tokyo, Japan

SS3-1EULAR: past, present, and future

Daniel Aletaha Medical University of Vienna, Austria

SS3-2Imaging and AI in rheumatology

Annamaria Iagnocco University of Turin, Italy

SS3-3Getting the diagnosis right: now and in the future - rheumatoid arthritis as an example

Gerd R. Burmester Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin, Berlin, Germany

SS3-4Management of Psoriatic Arthritis

Iain B. McInnes College of Medical, Veterinary & Life Sciences (MVLS), University of Glasgow, Glasgow, United Kingdom

SS3-5Management of rheumatoid arthritis

Josef S. Smolen Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Austria

SS 4(ACR Session)

Saturday, April 20 14:30-16:30 Room 11 ( International Conference Room, 3F, Kobe International Conference Center )

System biology and mechanism-based therapy in rheumatic disease

Chairs: Yoshiya Tanaka The First Department of internal Medicine, University of Occupational and Environmental Health, Japan
Hideto Kameda Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Japan

SS4-1Systems Biology in Rheumatic diseases (SLE)

Andrea Fava Division of Rheumatology, Johns Hopkins University, USA

SS4-2Pathologic Bone Resorption and New Bone Formation in Psoriatic Arthritis and Rheumatoid Arthritis, and Implications for Therapy

Christopher Ritchlin Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA

TREG Session

Saturday, April 20 9:10-11:10 Room 1 ( Portopia Hall, 1F, South Building, Kobe Portopia Hotel )

Conference analysis of ACR 2023 and EULAR 2023

Chairs: Yoshiya Tanaka The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan
Kunihiro Yamaoka Kitasato University School of Medicine, Japan

TS -1Systemic lupus erythematosus/ Autoimmune rheumatic disorders

Allan Gibofsky Weill Cornell Medicine and Attending Rheumatologist Hospital for Special Surgery, New York, NY, USA

TS -2New molecules in Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis ( RA), Sjögren's (pSS), Systemic Sclerosis (dSSc) and Behcet's disease (BD) presented at EULAR and ACR 2023

Roy M. Fleischmann University of Texas Southwestern Medical Center, Dallas, TX, USA

TS -3Progress in the Therapeutic Approach to Rheumatoid Arthritis (RA)

Arthur Kavanaugh University of California, San Diego. La Jolla, California, USA

TS -4Spondyloarthritis (PsA, axSpA)

Christopher Ritchlin Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA

Educational Lecture

EL 17

Friday, April 19 15:15-16:15 Room 14 (Convention Hall South, 1F, No.2 Building, Kobe International Exhibition Hall)

Osteoarthritis: Current Knowledge and Treatment from the Orthopaedic Surgeon's Perspective

Chair: Yasuharu Nakashima Department of Orthopaedic Surgery, Kyushu University, Japan
Lecturer: Stuart B. Goodman Department of Orthopaedic Surgery, Stanford University, Stanford, CA, USA

EL 18

Friday, April 19 16:25-17:25 Room 14 ( Convention Hall South, 1F, No.2 Building, Kobe International Exhibition Hall )

Perioperative Risk Mitigation: Guideline for Perioperative Care of the Rheumatic Disease Patient

Chair: Michiaki Takagi Department of Orthopaedic Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
Lecturer: Susan M. Goodman Hospital for Special Surgery, Weill Cornell Medicine, NYC, USA

Meet the Expert

MTE 11

Friday, April 19  8:40-9:40 MTE Room 1 ( 401, 4F, Kobe International Conference Center )

Keys to musculoskeletal physical exam

Lecturer: Masato Nagao University of California San Francisco, San Francisco, USA

MTE 12

Friday, April 19  9:50-10:50 MTE Room 1 ( 401, 4F, Kobe International Conference Center )

Physical examination of an arthritis or spondyloarthritis patient. The Scandinavian way to perform it

Lecturer: Markku J. Kauppi Faculty of Medicine, Clinicum, Helsinki University, Helsinki / Päijät-Häme Central Hospital, Lahti, Finland

Morning Seminar

MS 7

Rheumatoid Arthritis Treatment Updates:
Focus on The Evolution of IL-6 Inhibition Therapy in EULAR Recommendations

April 19 (Fri) 7:30-8:30 Room 12 (Main Hall, 1F, Kobe International Conference Center)

Chair: Tsutomu Takeuchi Saitama Medical University / Keio University
2022 Updated EULAR RA Management Recommendations in a Global Perspective
Speaker: Josef Smolen Division of Rheumatology Department of Medicine 3, Medical University of Vienna, Austria 
Sponsored: CHUGAI PHARMACEUTICAL CO., LTD.

MS 13

(draft) Treatment Strategy for RA

April 20 (Sat) 7:30-8:30 Room 10 (504+505, 5F, Kobe International Conference Center)

Chair: Kei Ikeda Department of Rheumatology, Dokkyo Medical University

TBD

MS 14

Up-to-date evidence in RA and SpA treatment

April 20 (Sat) 7:30-8:30 Room 11 (International Conference Room, 3F, Kobe International Conference Center)

Chair: Kunihiro Yamaoka Department of Rheumatology and Infectious Diseases,
Kitasato University School of Medicine, Kanagawa, Japan

TBD

Luncheon Seminar

LS 1

Modern management strategies for RA: achieving clinical and structural remission with filgotinib

April 18 (Thu) 12:15-13:15 Room 2 (Ohwada A, 1F, South Building, Kobe Portopia Hotel)

Chair: Tsutomu Takeuchi Saitama Medical University / Keio University
Speaker: Peter C.Taylor Norman Collisson Professor of Musculoskeletal Sciences, Nuffield
Dept. of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Sponsored: Gilead Sciences K.K. / Eisai co.,Ltd.

LS 3

The Role of Interleukin-6 in Rheumatoid Arthritis

April 18 (Thu) 12:15-13:15 Room 4 (Ohwada C, 1F, South Building, Kobe Portopia Hotel)

Chair: Yuko Kaneko Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
Speaker: Gerd R. Burmester Department of Rheumatology and Clinical Immunology Charité – Universitätsmedizin Berlin Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin, Germany
Sponsored: ASAHI KASEI PHARMA CORPORATION

LS 11

Update on the management of ILD in rheumatic diseases

April 18 (Thu) 12:15-13:15 Room 12 (Main Hall, 1F, Kobe International Conference Center)

Chair: Hidekata Yasuoka Department of Rheumatology, Department of Internal Medicine, Fujita Health University School of Medicine
Speaker: Anna Maria Hoffmann-vold Department of Rheumatology, Oslo University Hospital, Oslo, Norway
Sponsored: Nippon Boehringer Ingelheim Co., Ltd.

LS 12

Rheum Up to DateーPatient Based Risk Assessment in RA―

April 18 (Thu) 12:15-13:15 Room 13 (Convention Hall North, 1F, No.2 Building, Kobe International Exhibition Hall)

Chair: Kunihiro Yamaoka Depertment of Rheumatology and Infectious Diseases, Kitasato University School of Medicine

TBD

LS 14

Clinical significance of IL-23 in the treatment of Psoriatic arthritis

April 18 (Thu) 12:15-13:15 Room 15 (2A Meeting Room, 2F, No.2 Building, Kobe International Exhibition Hall)

Chair: Tadashi Okano Specially Appointed Professor, Center for Senile Degenerative Disorders (CSDD),
Osaka Metropolitan University Graduate School of Medicine
Speaker: Paul Bird St George Clinical School, University of New South Wales
Sponsored: Janssen Pharmaceutical K.K.

LS 16

Modernizing the clinical approach to RA management by preventing structural joint damage:
the JAK inhibitor filgotinib

April 19 (Fri) 12:05-13:05 Room 3 (Ohwada B, 1F, South Building, Kobe Portopia Hotel)

Chair: Tatsuya Atsumi Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan
Speaker: Peter C.Taylor Norman Collisson Professorof Musculoskeletal Sciences, Nuffield Dept. of Orthopaedics,Rheumatologyand Musculoskeletal Sciences,University of Oxford
Discussers: Kei Ikeda Department of Rheumatology, Dokkyo Medical University, Japan
Tomohiro Koga Department of Immunology and Rheumatology,
Division of Advanced Preventive Medical Sciences,
Nagasaki University Graduate School of Biomedical Sciences, Japan
Shuji Asai Department of Orthopedic Surgery,
Nagoya University Graduate School of Medicine, Japan
Sponsored: Gilead Sciences K.K. / Eisai co.,Ltd.

Evening Seminar

ES 2

Latest evidence update of a JAK inhibitor drug

April 18 (Thu) 16:45-18:15 Room 5 (Kairaku 1, B1, Main Building, Kobe Portopia Hotel)

Chair: Yoshiya Tanaka The First Department of Internal Medicine, iversity of Occupational and Environmental Health, Japan
Recent real-world evidence of baricitinib treatment in patients with rheumatoid arthritis
~ Japanese PMS data and the RA-BE-REAL study ~
Takao Fujii Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Japan
Baricitinib versus TNF-inhibitors in Patients with Rheumatoid Arthritis:
a Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target
Speaker: Mart A F J van de Laar Professor of Rheumatology, University of Twente, Enschede, Netherlands
Sponsored: Eli Lilly Japan K.K.

ES 9

Critical role of IL-6 Inhibition for Autoimmune Diseases

April 19 (Fri) 17:40-19:10 Room 2 (Ohwada A, 1F, South Building, Kobe Portopia Hotel)

Chair: Masataka Kuwana Department of Allergy and Rheumatology, Nippon Medical School, Japan
Kunihiro Yamaoka Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine 
ES9-1The Potential of IL-6 in Autoimmune Diseases from the Perspective of new imaging modality
Speaker: Georg Schett Department of Internal Medicine 3 Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg, Germany
ES9-2The Role of IL-6 in the etiology of rheumatoid arthritis
Satoshi Kubo University of Occupational and Environmental Health, Japan Department of Molecular Targeted Therapies
Sponsored: CHUGAI PHARMACEUTICAL CO., LTD.

ES 18

Treatment of Spondyloarthritis aiming for higher outcomes

April 19 (Fri) 17:40-19:10 Room 15 (2A Meeting Room, 2F, No.2 Building, Kobe International Exhibition Hall)

Chair: Shintaro Hirata Hiroshima University Hospital
Hideto Kameda Toho University
ES18-2Treatment goal in the management of spondyloarthritis
Yuko Kaneko Keio University
ES18-1Pathologic significance of IL-17A&F in the spondyloarthritis disease spectrum
Speaker: Iain McInnes University of Glasgow, UK
Sponsored: UCB Japan Co. Ltd.

page top